SEPD-363

N/A

Report date: 2025/01/26 17:05:03
NME

Base Information

Drug NameSEPD-363
Drug Alias NameNS5A inhibitor (Southeast Pharmaceuticals)SEPD-363
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNonstructural protein 5A inhibitors
TargetsNonstructural protein 5A
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Southeast Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Southeast Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A